JAMES B BREITMEYER Insider Trading $ONCT Oncternal Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JAMES B BREITMEYER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JAMES B BREITMEYER. JAMES B BREITMEYER is VP PHARMACEUTICAL OPERATIONS in CytoCore, Inc. ($AMEV) and Chief Executive Officer in Oncternal Therapeutics, Inc. ($GTXI) and President, CEO in GTX INC /DE/ ($GTXI) and Director in ZOGENIX, INC. ($ZGNX) and Director in OTONOMY, INC. ($OTIC).
JAMES B BREITMEYER in Oncternal Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JAMES B BREITMEYER: Chief Executive Officer, President, CEO
Holdings: 255,591 shares
Current Value: $1,426,198
Latest Transaction: Mar 22 2021
$ONCT Market Capitalization: $86.92M
$ONCT Previous Close: $5.58
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JAMES B BREITMEYER in Oncternal Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AMEV, ONCT, OTIC, ZGNX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 22 2021 | ONCT | Oncternal Therapeu ... | BREITMEYER JAMES B | Chief Executive Off ... | Option Exercise | A | 0.81 | 63,295 | 51,269 | 105,492 | |
| Feb 23 2021 | ONCT | Oncternal Therapeu ... | BREITMEYER JAMES B | Chief Executive Off ... | Option Exercise | A | 7.48 | 2,000 | 14,960 | 2,000 | |
| Feb 23 2021 | ONCT | Oncternal Therapeu ... | BREITMEYER JAMES B | Chief Executive Off ... | Option Exercise | A | 5.33 | 7,000 | 37,310 | 7,000 | |
| Mar 18 2020 | ONCT | Oncternal Therapeu ... | BREITMEYER JAMES B | Chief Executive Off ... | Option Exercise | A | 3.33 | 66,890 | 222,744 | 66,890 | |
| Jan 09 2020 | GTXI | Oncternal Therapeu ... | BREITMEYER JAMES B | Chief Executive Off ... | Option Exercise | A | 4.13 | 22,000 | 90,860 | 22,000 | |
| Sep 16 2019 | GTXI | Oncternal Therapeu ... | BREITMEYER JAMES B | Chief Executive Off ... | Option Exercise | A | 5.76 | 100,000 | 576,000 | 100,000 | |
| Jun 20 2019 | GTXI | Oncternal Therapeu ... | BREITMEYER JAMES B | President, CEO | Option Exercise | A | 0.81 | 42,196 | 34,179 | 42,196 | |
| Jun 11 2019 | GTXI | GTX INC /DE/ | BREITMEYER JAMES B | President, CEO | Option Exercise | A | 6.13 | 733 | 4,493 | 733 | |
| Jun 11 2019 | GTXI | GTX INC /DE/ | BREITMEYER JAMES B | President, CEO | Option Exercise | A | 0.68 | 1,467 | 998 | 1,467 | |
| Jun 11 2019 | GTXI | GTX INC /DE/ | BREITMEYER JAMES B | President, CEO | Option Exercise | A | 0.68 | 117,417 | 79,844 | 117,417 | |
| Jun 11 2019 | GTXI | GTX INC /DE/ | BREITMEYER JAMES B | President, CEO | Grant | A | 0.00 | 21,544 | 0 | 21,544 | 0 to 21.5 K |
| Jun 11 2019 | GTXI | GTX INC /DE/ | BREITMEYER JAMES B | President, CEO | Grant | A | 0.00 | 733 | 0 | 733 | 0 to 733 |
| Jun 11 2019 | GTXI | GTX INC /DE/ | BREITMEYER JAMES B | President, CEO | Grant | A | 0.00 | 255,591 | 0 | 255,591 | 0 to 255.6 K |
Page: 1